The FDA has approved Zynyz (retifanlimab-dlwr) to treat patients with squamous cell carcinoma of the anal canal.

Incyte INCY announced that the FDA has approved its new drug, Zynyz (retifanlimab-dlwr), a PD-1 inhibitor, for treating a new ...

The FDA has approved Emrelis to treat adults with locally advanced or metastatic NSCLC with high c-Met protein overexpression.

The FDA has granted fast-track approval to the drug telisotuzumab vedotin (sold as Emrelis) as a first-of-its-kind treatment for certain people who have non-squamous non-small-cell lung cancer.

Bayer BAYRY announced first-quarter 2025 results. Novo Nordisk NVO and GSK plc GSK announced licensing deals with smaller ...

With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help ...

From ingredient lists to skin sensitivities, picking out the right sunscreen is critical to your skin health. This ...

A cycle time measures the time from the date of submission, through date of approval. In the U.S., this is the time that it takes to get a drug approved ... focused on cancer patient recruitment ...

Importantly, under long-standing law and practice, NIH does not have the authority to arbitrarily terminate grants. Its ...

Thyroid support supplements are formulated to promote better thyroid health through a targeted combination of nutrients, minerals, and adaptogenic herbs. These compounds are selected based on their ...

Dedicated to the future of cancer treatment, this topic covers emerging targeted and immunotherapeutic approaches in solid tumors and hematologic ...